What does CUSIP 09058V103 represent in this 13F holders report?

CUSIP 09058V103 is the security identifier for BCRX - BIOCRYST PHARMACEUTICALS INC - Common Stock used to aggregate holder disclosures.

How many institutions held BCRX - BIOCRYST PHARMACEUTICALS INC - Common Stock in Q1 2015?

96 institutional investors reported BCRX - BIOCRYST PHARMACEUTICALS INC - Common Stock for Q1 2015. Use the holders table for investor-level position and value details.

BIOCRYST PHARMACEUTICALS INC - Common Stock (BCRX)

CUSIP: 09058V103

Q1 2015 13F Holders as of 31 Mar 2015

Type / Class: Equity / Common Stock
Shares outstanding: 210,587,372
Total 13F shares: 64,945,642
Share change: +4,266,245
Total reported value: $586,470,031
Put/Call ratio: 84%
Price per share: $9.03
Number of holders: 96
Value change: +$36,664,370
Number of buys: 56
Number of sells: 40

Quarterly Holders Quick Answers

What is CUSIP 09058V103?
CUSIP 09058V103 identifies BCRX - BIOCRYST PHARMACEUTICALS INC - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2015
Previous quarter: Q4 2014

Recent filing periods for CUSIP 09058V103:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of BCRX - BIOCRYST PHARMACEUTICALS INC - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BAKER BROS. ADVISORS LP	13F	Company	5.1%	10,713,686	$130,278,000	—	31 Dec 2014	13F
FMR LLC	13F	Company	5%	10,424,425	$126,761,000	—	31 Dec 2014	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	3.5%	7,389,273	$89,854,000	—	31 Dec 2014	13F
RA CAPITAL MANAGEMENT, L.P.	13F	Company	3.3%	7,050,356	$85,732,000	—	31 Dec 2014	13F
BlackRock Fund Advisors	13F	Company	1.3%	2,804,541	$34,103,000	—	31 Dec 2014	13F
STATE STREET CORP	13F	Company	1.3%	2,790,435	$33,933,000	—	31 Dec 2014	13F
VANGUARD GROUP INC	13F	Company	1.1%	2,284,328	$27,778,000	—	31 Dec 2014	13F
RTW INVESTMENTS, LP	13F	Company	1.1%	2,261,361	$27,498,000	—	31 Dec 2014	13F
BlackRock Institutional Trust Company, N.A.	13F	Company	0.91%	1,912,804	$23,260,000	—	31 Dec 2014	13F
VHCP Management, LLC	13F	Company	0.83%	1,744,356	$21,211,000	—	31 Dec 2014	13F
D. E. Shaw & Co., Inc.	13F	Company	0.79%	1,670,539	$20,313,000	—	31 Dec 2014	13F
QVT Financial LP	13F	Company	0.59%	1,246,282	$15,155,000	—	31 Dec 2014	13F
NORTHERN TRUST CORP	13F	Company	0.4%	839,066	$10,202,000	—	31 Dec 2014	13F
Cormorant Asset Management, LP	13F	Company	0.38%	800,000	$9,728,000	—	31 Dec 2014	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.23%	478,383	$5,818,000	—	31 Dec 2014	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	0.23%	475,435	$5,782,000	—	31 Dec 2014	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.2%	419,905	$5,106,000	—	31 Dec 2014	13F
Bank of New York Mellon Corp	13F	Company	0.17%	366,332	$4,454,000	—	31 Dec 2014	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.17%	352,554	$4,287,000	—	31 Dec 2014	13F
BLACKROCK ADVISORS LLC	13F	Company	0.16%	343,106	$4,172,000	—	31 Dec 2014	13F
AXA S.A.	13F	Company	0.15%	325,587	$3,959,000	—	31 Dec 2014	13F
GUGGENHEIM CAPITAL LLC	13F	Company	0.13%	264,963	$3,222,000	—	31 Dec 2014	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.12%	258,475	$3,143,000	—	31 Dec 2014	13F
S.c.a. Candriam	13F	Individual	0.12%	253,000	$3,076,000	—	31 Dec 2014	13F
BlackRock Investment Management, LLC	13F	Company	0.11%	224,364	$2,728,000	—	31 Dec 2014	13F
Connor, Clark & Lunn Investment Management Ltd.	13F	Company	0.1%	213,098	$2,591,000	—	31 Dec 2014	13F
DAFNA Capital Management LLC	13F	Company	0.08%	166,656	$2,027,000	—	31 Dec 2014	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.08%	160,500	$1,775,000	—	31 Dec 2014	13F
BlackRock Group LTD	13F	Company	0.07%	143,195	$1,741,000	—	31 Dec 2014	13F
MACQUARIE GROUP LTD	13F	Company	0.07%	142,167	$1,729,000	—	31 Dec 2014	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.06%	129,787	$1,578,000	—	31 Dec 2014	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.05%	107,800	$1,311,000	—	31 Dec 2014	13F
UNITED SERVICES AUTOMOBILE ASSOCIATION	13F	Company	0.05%	106,806	$1,299,000	—	31 Dec 2014	13F
SIT INVESTMENT ASSOCIATES INC	13F	Company	0.05%	104,525	$1,271,000	—	31 Dec 2014	13F
FRANKLIN STREET ADVISORS INC /NC	13F	Company	0.05%	99,000	$1,204,000	—	31 Dec 2014	13F
TEACHERS ADVISORS, LLC	13F	Company	0.05%	98,183	$1,194,000	—	31 Dec 2014	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.04%	90,268	$1,098,000	—	31 Dec 2014	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.04%	84,226	$1,024,000	—	31 Dec 2014	13F
Iguana Healthcare Management, LLC	13F	Company	0.04%	75,000	$912,000	—	31 Dec 2014	13F
UBS Group AG	13F	Company	0.03%	70,574	$858,000	—	31 Dec 2014	13F
NATIONAL PLANNING CORP	13F	Company	0.03%	70,050	$845,504	—	31 Dec 2014	13F
RHUMBLINE ADVISERS	13F	Company	0.03%	69,084	$840,000	—	31 Dec 2014	13F
CREDIT SUISSE AG/	13F	Company	0.03%	67,353	$819,000	—	31 Dec 2014	13F
Swiss National Bank	13F	Company	0.03%	66,300	$806,000	—	31 Dec 2014	13F
Nationwide Fund Advisors	13F	Company	0.03%	65,677	$799,000	—	31 Dec 2014	13F
MASON STREET ADVISORS, LLC	13F	Company	0.03%	64,300	$782,000	—	31 Dec 2014	13F
BlackRock Finance, Inc.	13F	Company	0.03%	63,617	$774,000	—	31 Dec 2014	13F
ProShare Advisors LLC	13F	Company	0.03%	62,577	$761,000	—	31 Dec 2014	13F
MORGAN STANLEY	13F	Company	0.03%	61,194	$745,000	—	31 Dec 2014	13F
METROPOLITAN LIFE INSURANCE CO/NY	13F	Company	0.03%	54,718	$665,000	—	31 Dec 2014	13F

Institutional Holders of BIOCRYST PHARMACEUTICALS INC - Common Stock (BCRX) as of Q1 2015

As of 31 Mar 2015, BIOCRYST PHARMACEUTICALS INC - Common Stock (BCRX) was held by 96 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 64,945,642 shares. The largest 10 holders included FMR LLC, BAKER BROS. ADVISORS LP, WELLINGTON MANAGEMENT GROUP LLP, RA CAPITAL MANAGEMENT, LLC, STATE STREET CORP, BlackRock Fund Advisors, VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, RTW INVESTMENTS, LLC, and BlackRock Institutional Trust Company, N.A.. This page lists 96 institutional shareholders reporting positions in this security for the Q1 2015 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2015 vs Q4 2014 Across Filers

Q4 2014 holders

Q1 2015 holders

Holder diff

Investor	Q4 2014 Shares	Q1 2015 Shares	Share Diff	Share Chg %	Q4 2014 Value $	Q1 2015 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.